Refolding mutant p53: a simple way to resolve a complex problem?
Zeimet
Alain G
AG
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016326:Extracellular Matrix Proteins / Q000235:genetics*; D006801:Humans; D009369:Neoplasms / Q000628:therapy*
D000970:Antineoplastic Agents; C403672:EFEMP2 protein, human; D016326:Extracellular Matrix Proteins